Anticorps Recombinant de lapin anti-c-Met (Cytoplasmic)
c-Met (Cytoplasmic) Recombinant Antibody for WB, FC (Intra), ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, FC (Intra), ELISA
Conjugaison
Non conjugué
CloneNo.
2G12
N° de cat : 82904-1-RR
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules HepG2, cellules HEK-293, tissu hépatique de rat, tissu hépatique de souris |
| Résultats positifs en FC (Intra) | cellules HeLa, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:10000 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
82904-1-RR cible c-Met (Cytoplasmic) dans les applications de WB, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | c-Met (Cytoplasmic) Protéine recombinante Ag23140 |
| Nom complet | met proto-oncogene (hepatocyte growth factor receptor) |
| Masse moléculaire calculée | 1390 aa, 155 kDa |
| Poids moléculaire observé | 140 kDa |
| Numéro d’acquisition GenBank | BC130420 |
| Symbole du gène | MET |
| Identification du gène (NCBI) | 4233 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
c-Met (also named MET or HGFR) is a receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to the HGF ligand. c-Met regulates many physiological processes including proliferation, scattering, morphogenesis, and survival. The primary single-chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide-linked to form the mature receptor. Overexpression and/or mutation of c-Met has been reported in various human malignancies, including lung cancer, breast cancer, head and neck cancer, gastric cancer, colorectal cancer, bladder cancer, uterine cervix carcinoma, esophageal carcinoma, c-Met could serve as an important therapeutic target (PMID: 26036285). The c-met receptor is a 190-kD glycoprotein consisting of a 145-kD membrane-spanning beta chain and a 50-kD alpha chain (PMID: 7806559). In Western blot, this antibody produces bands of unknown identity at 55 and 100 kDa.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for c-Met (Cytoplasmic) antibody 82904-1-RR | Download protocol |
| FC protocol for c-Met (Cytoplasmic) antibody 82904-1-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |






